Glaucoma and ocular hypertension are serious eye conditions that can gradually lead to vision loss—or even blindness—if left untreated. Glaucoma occurs when elevated pressure inside the eye, known as intraocular pressure (IOP), damages the optic nerve. Often, glaucoma progresses without noticeable symptoms or pain in its early stages, making regular eye exams crucial for early detection. Fortunately, when diagnosed early, effective treatments can help manage the condition, protecting vision and preventing permanent damage.
iDose® TR is an innovative, micro-sized implant that provides a continuous release of glaucoma medication directly inside your eye. This advanced technology ensures effective eye pressure control – without the need for daily eye drops. iDose® TR addresses common challenges like compliance, fluctuating medication levels, and inconvenient daily dosing, it is designed to offer patients a more consistent, reliable way to manage their eye pressure and protect their vision.
Unlike traditional eye drops that require daily application, iDose® TR is a micro-sized implant for glaucoma that releases a steady dose of Travoprost directly into the eye over an extended period. Travoprost is a powerful medication known for effectively lowering intraocular pressure (IOP) by increasing the outflow of fluid from the eye. iDose® TR continuously delivers this medication to help maintain stable eye pressure and protect the optic nerve from damage that can lead to vision loss.
The iDose® TR implant is placed inside the eye during a minimally invasive outpatient procedure. It is carefully positioned within the eye’s anterior chamber via a tiny incision, where it remains secure and stable, providing a hands-free solution to IOP management. Made from biocompatible materials like medical-grade titanium and an ethylene vinyl acetate (EVA) membrane, iDose® TR is designed to remain safely in place without being felt or noticed by the patient.
iDose® TR is an excellent treatment option for patients with open-angle glaucoma or ocular hypertension who are seeking an alternative to the daily routine of glaucoma eye drops. This treatment is also suitable for those who have experienced side effects from traditional glaucoma medications, such as eye redness, irritation, or changes in the eye’s appearance. Since iDose® TR delivers medication directly to the eye over time, it significantly reduces the risk of these side effects, allowing patients to manage their glaucoma more comfortably.